AAAAAA
Results:
1-14
|
Results: 14
Authors:
McClain, JB
Edelman, R
Shmuklarsky, M
Que, J
Cryz, SJ
Cross, AS
Citation: Jb. Mcclain et al., Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiellaserotypes after intravenous infusion, VACCINE, 19(25-26), 2001, pp. 3499-3508
Authors:
Kollaritsch, H
Cryz, SJ
Lang, AB
Herzog, C
Que, JU
Wiedermann, G
Citation: H. Kollaritsch et al., Local and systemic immune responses to combined Vibrio cholerae CVD103-HgRand Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization, VACCINE, 18(26), 2000, pp. 3031-3039
Authors:
Richie, E
Punjabi, NH
Sidharta, Y
Peetosutan, K
Sukandar, M
Wasserman, SS
Lesmana, M
Wangsasaputra, F
Pandam, S
Levine, MM
O'Hanley, P
Cryz, SJ
Simanjuntak, CH
Citation: E. Richie et al., Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area, VACCINE, 18(22), 2000, pp. 2399-2410
Authors:
Dilts, DA
Riesenfeld-Orn, I
Fulginiti, JP
Ekwall, E
Granert, C
Nonenmacher, J
Brey, RN
Cryz, SJ
Karlsson, K
Bergman, K
Thompson, T
Hu, B
Bruckner, AH
Lindberg, AA
Citation: Da. Dilts et al., Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S-typhivaccines; effect of formulation on safety and immunogenicity, VACCINE, 18(15), 2000, pp. 1473-1484
Authors:
Panpitpat, C
Thisyakorn, U
Chotpitayasunondh, T
Furer, E
Que, JU
Hasler, T
Cryz, SJ
Citation: C. Panpitpat et al., Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine, B WHO, 78(3), 2000, pp. 364-371
Authors:
Gluck, R
Mischler, R
Durrer, P
Furer, E
Lang, AB
Herzog, C
Cryz, SJ
Citation: R. Gluck et al., Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant, J INFEC DIS, 181(3), 2000, pp. 1129-1132
Authors:
Rubinstein, A
Mizrachi, Y
Pettoello-Mantovani, M
Lenz, J
Liu, GQ
Rubinstein, Y
Goldstein, H
Yust, I
Burke, M
Vardinon, N
Spirer, Z
Cryz, SJ
Citation: A. Rubinstein et al., Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates, J ACQ IMM D, 22(5), 1999, pp. 467-476
Authors:
Cryz, SJ
Citation: Sj. Cryz, BERNA: a century of immunobiological innovation - Introduction, VACCINE, 17, 1999, pp. S1-S5
Authors:
Cross, AS
Opal, SM
Bhattacharjee, AK
Donta, ST
Peduzzi, PN
Furer, E
Que, JU
Cryz, SJ
Citation: As. Cross et al., Immunotherapy of sepsis: flawed concept or faulty implementation?, VACCINE, 17, 1999, pp. S13-S21
Authors:
Richie, E
Punjabi, NH
Harjanto, SJ
Wangsasaputral, F
Sukandar, M
Supriatman, M
Simanjuntak, CH
Que, JU
Cryz, SJ
Citation: E. Richie et al., Safety and immunogenicity of combined diphtheria tetanus pertussis (whole cell and acellular) Haemophilus influenzae b conjugate vaccines administered to Indonesian children, VACCINE, 17(11-12), 1999, pp. 1384-1393
Authors:
Tsai, TF
Kollaritsch, H
Que, JU
Cropp, CB
Kunz, C
Wiedermann, G
Herzog, C
Cryz, SJ
Citation: Tf. Tsai et al., Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated cholera CVD103-HgR and typhoid Ty21a vaccines, J INFEC DIS, 179(2), 1999, pp. 522-524
Authors:
Viret, JF
Favre, D
Wegmuller, B
Herzog, C
Que, JU
Cryz, SJ
Lang, AB
Citation: Jf. Viret et al., Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria, INFEC IMMUN, 67(7), 1999, pp. 3680-3685
Authors:
Taylor, DN
Sanchez, JL
Castro, JM
Lebron, C
Parrado, CM
Johnson, DE
Tacket, CO
Losonsky, GA
Wasserman, SS
Levine, MM
Cryz, SJ
Citation: Dn. Taylor et al., Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama, INFEC IMMUN, 67(4), 1999, pp. 2030-2034
Authors:
Tacket, CO
Cohen, MB
Wasserman, SS
Losonsky, G
Livio, S
Kotloff, K
Edelman, R
Kaper, JB
Cryz, SJ
Giannella, RA
Schiff, G
Levine, MM
Citation: Co. Tacket et al., Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination, INFEC IMMUN, 67(12), 1999, pp. 6341-6345
Risultati:
1-14
|